Filing Details

Accession Number:
0001209191-15-072348
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-28 19:14:16
Reporting Period:
2015-09-25
Filing Date:
2015-09-28
Accepted Time:
2015-09-28 19:14:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1011835 Medivation Inc. MDVN Pharmaceutical Preparations (2834) 133863260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1311210 Patrick Clarence Machado C/O Medivation, Inc.
525 Market St., 36Th Floor
San Francisco CA 94105
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-25 71,980 $4.69 138,136 No 4 M Direct
Common Stock Disposition 2015-09-25 11,600 $40.82 125,536 No 4 S Direct
Common Stock Disposition 2015-09-25 22,236 $41.63 104,300 No 4 S Direct
Common Stock Disposition 2015-09-25 20,464 $42.68 83,836 No 4 S Direct
Common Stock Disposition 2015-09-25 17,680 $43.92 66,156 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-09-25 71,980 $0.00 71,980 $4.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-10-30 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. The shares were sold at prices between $40.32 and $41.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares were sold at prices between $41.33 and $42.32. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The shares were sold at prices between $42.34 and $43.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The shares were sold at prices between $43.45 and $44.31. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. Fully vested.